1. Medtech Insight
  2. >>Policy & Regulation

$18.4 Million In User Fees Left In CDRH’s Coffers, How Long Will It Last?

The device center says it had $18.4 million in user fees remaining as of Oct. 1 to continue its work focused solely on user-fee funded activities, but the agency is unsure how long the funds will last if the government shutdown continues.

CDRH says it had $18.4 million remaining in medical device fiscal year 2013 user fees as of Oct. 1 to use on reviewing already-submitted device applications and other user-fee funded activities. But the agency can’t say how much longer the funds will last if the government shutdown continues.

“My understanding is that the medical device user-fee carryover probably will only sustain people working for about a month, plus or minus,” Steven Grossman, deputy executive director of Alliance for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.